( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
464020
454790
444900
422790
Total Expenditure
352350
348450
339550
323360
PBIDT (Excl OI)
111670
106340
105350
99430
Other Income
11590
11390
9820
10420
Operating Profit
123260
117730
115170
109850
Exceptional Items
NA
-12890
NA
NA
PBDT
122210
103840
114110
108800
Depreciation
14240
11550
11820
11400
Profit Before Tax
107970
92290
102290
97400
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
85090
66660
73750
69240
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
85090
66660
73750
69240
Minority Interest
-80
-120
-110
-30
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
85010
66540
73640
69210
Equity Capital
20240
20240
20740
20740
Reserves
908280
937450
937450
937450
Calculated EPS
21.00
16.43
17.75
16.68
Calculated EPS (Annualised)
84.00
65.75
71.01
66.74
No of Public Share Holdings
3211043645
3177235197
3248006873
3169183403
% of Public Share Holdings
85.62
85.48
85.7
85.39
PBIDTM% (Excl OI)
24.06
23.38
23.67
23.51
PBIDTM%
26.56
25.88
25.88
25.98
PBDTM%
26.33
22.83
25.64
25.73
PBTM%
23.26
20.29
22.99
23.03
PATM%
18.33
14.65
16.57
16.37